Risk factors for periorbital dermatitis in patients using dorzolamide/timolol eye drops
Abstract This study assessed the clinical risk factors for periorbital dermatitis (PD) after using dorzolamide/timolol eye drops in a total of 1282 glaucoma patients. Both the PD(+) group and the PD(−) group were evaluated using clinical data such as age, sex, dosing duration, presence of benzalkoni...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/e3f88d173aec4c2baf3a503b9d1d7a25 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|